Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
84.98
-0.66 (-0.77%)
Nov 21, 2024, 12:03 PM EST - Market open
Intra-Cellular Therapies Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$97.67
Upside
+14.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $81 → $89 | Buy | Maintains | $81 → $89 | +4.73% | Nov 4, 2024 |
| Needham | Needham | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +17.67% | Oct 31, 2024 |
| Needham | Needham | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +17.67% | Oct 30, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $92 → $95 | Buy | Maintains | $92 → $95 | +11.79% | Oct 11, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $106 → $108 | Buy | Maintains | $106 → $108 | +27.09% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $130 | Buy | Reiterates | $130 | +52.98% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $130 | Buy | Reiterates | $130 | +52.98% | Sep 16, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $68 → $92 | Hold → Buy | Upgrades | $68 → $92 | +8.26% | Sep 6, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $79 → $81 | Buy | Maintains | $79 → $81 | -4.68% | Aug 21, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $107 → $106 | Buy | Maintains | $107 → $106 | +24.74% | Aug 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $120 → $130 | Buy | Maintains | $120 → $130 | +52.98% | Aug 8, 2024 |
| UBS | UBS | Hold Maintains $83 → $79 | Hold | Maintains | $83 → $79 | -7.04% | Aug 8, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $77 → $74 | Hold | Maintains | $77 → $74 | -12.92% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +17.67% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +17.67% | Aug 7, 2024 |
| Needham | Needham | Strong Buy Maintains $94 → $100 | Strong Buy | Maintains | $94 → $100 | +17.67% | Jul 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.